Outset Medical Price to Sales Ratio 2019-2024 | OM
Outset Medical P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-05-09 | 15.30 | 0.46 | |
2024-12-31 | 16.65 | $33.23 | 0.50 |
2024-09-30 | 10.16 | $33.95 | 0.30 |
2024-06-30 | 57.75 | $34.55 | 1.67 |
2024-03-31 | 33.30 | $37.68 | 0.88 |
2023-12-31 | 81.15 | $39.67 | 2.05 |
2023-09-30 | 163.20 | $40.41 | 4.04 |
2023-06-30 | 328.05 | $39.94 | 8.21 |
2023-03-31 | 276.00 | $36.74 | 7.51 |
2022-12-31 | 387.30 | $36.10 | 10.73 |
2022-09-30 | 238.95 | $35.40 | 6.75 |
2022-06-30 | 222.90 | $35.22 | 6.33 |
2022-03-31 | 681.00 | $35.65 | 19.10 |
2021-12-31 | 691.35 | $34.04 | 20.31 |
2021-09-30 | 741.60 | $40.59 | 18.27 |
2021-06-30 | 749.70 | $48.89 | 15.34 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.055B | $0.114B |
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
Tempus AI (TEM) | United States | $10.569B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
Privia Health (PRVA) | United States | $3.035B | 208.50 |
Enovis (ENOV) | United States | $1.887B | 10.53 |
Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
Schrodinger (SDGR) | United States | $1.746B | 0.00 |
Phreesia (PHR) | United States | $1.506B | 0.00 |
Azenta (AZTA) | United States | $1.223B | 56.96 |
Omnicell (OMCL) | United States | $1.208B | 21.31 |
10x Genomics (TXG) | United States | $1.073B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.600B | 0.00 |
Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
Talkspace (TALK) | United States | $0.509B | 151.00 |
Veradigm (MDRX) | United States | $0.466B | 0.00 |
Standard BioTools (LAB) | United States | $0.406B | 0.00 |
TruBridge (TBRG) | United States | $0.371B | 827.00 |
Claritev (CTEV) | United States | $0.351B | 0.00 |
Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
Pulmonx (LUNG) | United States | $0.136B | 0.00 |
American Well (AMWL) | United States | $0.107B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
CareCloud (CCLD) | United States | $0.081B | 3.07 |
111 (YI) | China | $0.068B | 0.00 |
P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.060B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |